Situaciones de broncoespasmo, obstrucción de las vías aéreas superiores, hipersecreción bronquial y determinadas características de los circuitos externos del. Contraindicada en casos de hipersensibilidad a la levodropropizina o compuestos estructuralmente relacionados, hipersecreción bronquial o función. Se asocia a: Hiperreactividad bronquial con episodios recurrentes de sibilancias, disnea, opresión torácica y tos. Obstrucción bronquial difusa.
|Genre:||Health and Food|
|Published (Last):||12 February 2012|
|PDF File Size:||14.55 Mb|
|ePub File Size:||11.33 Mb|
|Price:||Free* [*Free Regsitration Required]|
Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Official Statement of the European Respiratory Society.
Asma Bronquial by Camila Tiznado on Prezi
hipresecrecion The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry. Clinical interpretation of airway response to a bronchodilator: Repeatibility of spirometry in 18, adult patients.
Exercise training and inspiratory muscle training in patients with bronchiectasis. Brain B, et al. J Clin Pharm Ther. Aerosolized vancomycin for the treatment of methicillin-resistant staphylococcus aureus infection in cystic fibrosis.
Measurement of reversibility of airways obstruction: Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? This abstract may be abridged. Double-blind randomized multicenter study versus placebo.
Association between fraction of exhaled nitrous oxide, bronchodilator response and inhaled corticosteroid type. Randomized, controlled, double blind, parallel, prospective design with rescue medication. Inhaled steroids in patients with bronchiectasis. A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis.
Eur J Respir Dis Suppl. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Role of bromhexine in exacerbations of bronchiectasis. Bronchodilator response as a marker of poor asthma control. Lung volumes and forced ventilatory flows.
A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Improved criterion for assessing lung function reversibility. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Influence of clinical diagnosis, spirometric and anthropometric variables.
American College of Chest Physicians. Clinical efficacy and safety of budesonide—formoterol in non—cystic fibrosis bronchiectasis. Cochrane Database Syst Rev. Long-term mortality among adults with asthma: Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas.
Effects of longterm use of macrolides in patients with non-cystic fibrosis bronchiectasis: Short- and bgonquial antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.
Nebulized amoxicillin in chronic purulent bronchiectasis. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis. Kellett F, Robert NM.
UK Cystic Fibrosis Trust. Am Bronquia, Respir Dis. No adverse events were reported with acebrophylline. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non cystic fibrosis bronchiectasis: Safety and tolerability of medication were also evaluated.
Monografías de Archivos de Bronconeumología
There was no difference in tolerability between the two groups. Similarly, there was no-significant increase in FAV1 in the acebrophylline group and a slight decrease in the placebo group.
However, users may print, download, or email articles for individual use. A pilot study of low-dose erythromycin in bronchiectasis. Comparison of hipersecrecoin responsiveness in asthma and chronic obstructive pulmonary disease. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. A genome-wide association study of bronchodilator response in asthmatics.
Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. However, remote access to EBSCO’s databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution. The disease-modifying effects of twiceweekly oral azithromycin in patients with bronchiectasis. Users should refer to the original published version of the material for the full abstract.